We are live on ! Find out more

HQH

abrdn Healthcare Investors

HQH

Market cap $1.22B

21.39 USD

-0.59

2.68%

At close Updated Sep 15, 4:00 PM EDT

1 day

-2.68%

5 days

-4.51%

1 month

-9.63%

3 months

9.58%

6 months

17.79%

Year to date

13.35%

1 year

29.95%

5 years

-19.4%

10 years

-11.76%

About: abrdn Healthcare Investors Formerly Tekla Healthcare Investors is the United States based non-diversified closed-end management investment company. Its objective is to seek long-term capital appreciation by investing in securities of healthcare companies. In addition, the fund seeks to provide regular distribution of realized capital gains. The fund invests in the securities of public and private companies.

Financials Asset Management

News

Positive

Neutral

Negative

Sentiment 3-Months

Positive 80%

Neutral 20%

Negative 0%

Opportunity To Catch 2 Income Picks Before Their Yield Goes Higher

The "Base + Commission" Portfolio: Combining fixed-rate debt and preferreds with formulaic, NAV-linked variable CEFs creates a solid baseline of income with automated upside during bull markets. RVT's quarterly payout is tracking up from $0.31 to $0.33 in September, with additional regular and special year-end dividend upside in play. HQH's September payout is set to reach $0.66 per share – its highest single quarterly distribution since 2015 – with strong potential for a year-end special distribution.

Opportunity To Catch 2 Income Picks Before Their Yield Goes Higher

HQH: After Biotech's Breakout Year, This Healthcare CEF Still Trades Below NAV; Buy

Abrdn Healthcare Investors is a concentrated, actively managed biotech-focused CEF trading at a 6.4% discount to NAV. I rate HQH a Buy: the fund delivered a 56% NAV return in twelve months, benefiting from an FDA regulatory shift and M&A tailwinds. The near-12% distribution is entirely funded by realized gains, not return of capital, distinguishing HQH from most high-payout CEFs.

HQH: After Biotech's Breakout Year, This Healthcare CEF Still Trades Below NAV; Buy

2 Lower-Risk Fat Dividends You Can't Ignore

There is no universally "best" investment; successful portfolios combine complementary strengths. We discuss why dependable dividends are essential to long-term wealth creation. Our two high-yield picks provide reliable income from very different corners of the market; yields +6%.

2 Lower-Risk Fat Dividends You Can't Ignore

Establishing A High-Yield Portfolio For Any Economic Conditions

Managed, leveraged fixed-income funds offer liquidity and instant diversification across thousands of complex institutional credit facilities. Strengthening demographic demand from an aging U.S. population delivers acyclical structural tailwinds to healthcare investments. Broad closed-end funds convert standard large- and small-cap stock movements into highly visible, managed distributions.

Establishing A High-Yield Portfolio For Any Economic Conditions

Ride The Silver Tsunami With Big Dividends; Yields +8%

Healthcare sector demand is set to surge due to global aging and declining fertility rates, driving resilient, long-term growth opportunities. As income investors, even with the most powerful tailwinds, we seek means to secure steady cash flows from our investments. We discuss our top picks to ride the Silver Tsunami, with yields +8%.

Ride The Silver Tsunami With Big Dividends; Yields +8%

The Withdrawal Trap: Why Paper Wealth Fails Retirees

Always build your portfolio around your unique lifestyle goals—don't end up standing on a beach in snow pants. Mimicking ultra-wealthy founders is dangerous. Billionaires have completely different financial goals, skills, and timelines than retirees. Warren Buffett's empire relies on controlling operating companies and a massive Treasury bill hoard, not simple stock-picking.

The Withdrawal Trap: Why Paper Wealth Fails Retirees

HQH: GLP-1 Market Growth Offers Upside But Portfolio Structure A Bit Inefficient

abrdn Healthcare Investors offers diversified healthcare exposure with a high yield, but structural inefficiencies persist. HQH trades near its narrowest historical discount to NAV, making current valuation less attractive versus its five-year average. The fund's high payout relies on net realized gains, risking NAV erosion and inconsistent dividend coverage during sector downturns.

HQH: GLP-1 Market Growth Offers Upside But Portfolio Structure A Bit Inefficient

Certain Aberdeen Investments U.S. Closed-End Funds Declare Distribution Dates and Amounts

PHILADELPHIA, May 11, 2026 /PRNewswire/ -- The following Aberdeen Investments U.S. Closed-End Funds (NYSE: ACP, AGD, AOD, ASGI, AWP, HQH, HQL, IFN, THQ, THW and NYSE American: FAX, IAF, VFL), announced today that the closed end funds in the chart directly below will pay the distributions indicated on a per share basis on May 29, 2026 to all shareholders of record as of May 21, 2026 (ex-dividend date May 21, 2026). The abrdn Healthcare Investors (HQH), the abrdn Life Sciences Investors (HQL), the abrdn Australia Equity Fund, Inc. (IAF), and the India Fund, Inc. (IFN) will pay their distributions on June 30, 2026, to shareholders of record as of May 21, 2026 (ex‑dividend date May 21, 2026).

Certain Aberdeen Investments U.S. Closed-End Funds Declare Distribution Dates and Amounts

Variable Payouts, Permanent Income: Why I'm Buying These 11% Yields Today

Variable policies prevent funds from over-distributing and eroding the long-term capital base. HQH: Secure a 3% quarterly payout from the cutting edge of biotech and pharmaceutical innovation. USA: Get broad, large-cap exposure while maintaining a double-digit yield through five elite management teams.

Variable Payouts, Permanent Income: Why I'm Buying These 11% Yields Today

I Demand Recurrent Income For My Retirement

Investors have thousands of choices. Your preferences matter, and knowing what you want sharpens your decision-making. Income-focused discipline creates real clarity and confidence.

I Demand Recurrent Income For My Retirement

See News Rankings

Price charts implemented using Lightweight Charts™